Miramar Eye Specialists Medical Group is the only center in Ventura County that can benefit patients by enrolling them in clinical studies.
Clinical Studies are conducted to determine specific answers to questions about the effectiveness or safety of a new medical device, drug, or surgical technique which improve eye health.
Why Should You Participate?
You can receive new and effective drugs to treat your condition. You will also have an opportunity to participate in the potential advancement of medication for others. You will gain access to treatments that are not yet to market which may improve your quality of life and vision.
If you like to inquire about the studies listed below please contact Crystal Segura, 805-275-4602, crystals@mesmg.com
Current Studies:
Glaucoma Study: Dr. John Davidson is evaluating an Intraocular Implant containing a slow release of glaucoma medication placed in the eye.
To be eligible for the study, you must:
- Be 18 years or older
- Meet Study-Related criteria
Participants Receive:
- Thorough screening evaluation of your eye health
- Follow-up visits for up to 3 years
- Reimbursement for the cost related to time and travel
- For more information, please visit www.GlaukosClinicalTrials.com
Diabetes Study: Dr. Joel Corwin is evaluating a new medication used to treat Diabetic Macular Edema (DME). To be eligible for the study, you must:
- 18 years or older
- Diagnosed with Type 1 or 2 Diabetes
- Hemoglobin A1c 12% or greater at screening
Participants Receive:
- Thorough screening evaluation of your eye health
- Follow-up visits for 1 year
Macular Degeneration: Enrollment started early 2020 for patients who have not had any treatment for Age-Related Macular Degeneration (AMD)
At Miramar we participate in more phase III Drug studies than many University Centers. We are the only center in Ventura County to offer so much cutting-edge care.
If you or anyone you know has any of the above serious eye problems, please contact Crystal Segura, Director of Research, or Joel Corwin M.D., Founder and Principal Investigator, for an evaluation.
CONTACT: Crystal Segura, 805-275-4602, crystals@mesmg.com